BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24022086)

  • 1. Responsiveness of neoadjuvant chemotherapy before surgery predicts favorable prognosis for cervical cancer patients: a meta-analysis.
    Ye Q; Yuan HX; Chen HL
    J Cancer Res Clin Oncol; 2013 Nov; 139(11):1887-98. PubMed ID: 24022086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients.
    Kong X; Moran MS; Zhang N; Haffty B; Yang Q
    Eur J Cancer; 2011 Sep; 47(14):2084-90. PubMed ID: 21737257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of responsiveness of neoadjuvant chemotherapy before surgery for patients with stage IB(2)/IIA(2) cervical cancer.
    Li R; Lu ST; Si JG; Liu B; Wang H; Mei YY; Linghu H
    Gynecol Oncol; 2013 Mar; 128(3):524-9. PubMed ID: 23146686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired treatment response from neoadjuvant chemotherapy predicts a favorable prognosis for local advanced cervical cancer: A meta-analysis.
    Zhu Y; Yang J; Zhang X; Chen D; Zhang S
    Medicine (Baltimore); 2018 Apr; 97(17):e0530. PubMed ID: 29703026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of neoadjuvant chemotherapy plus radical surgery in patients with bulky stage II cervical squamous cell carcinoma: A retrospective cohort study.
    Qin T; Zhen J; Zhou M; Wu H; Ren R; Qu B; Wang H
    Int J Surg; 2016 Jun; 30():121-5. PubMed ID: 27131759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric/gastroesophageal cancer: a meta-analysis.
    Ge L; Wang HJ; Yin D; Lei C; Zhu JF; Cai XH; Zhang GQ
    World J Gastroenterol; 2012 Dec; 18(48):7384-93. PubMed ID: 23326149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Meta analysis of whether cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy can improve survival in patients with colorectal cancer peritoneal metastasis].
    Liu D; Wang H; Yuan ZX; Chen WW; Wu ZJ; Liu XX; Luo J; Chu LL; Li Y; Cai J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):256-263. PubMed ID: 34645170
    [No Abstract]   [Full Text] [Related]  

  • 8. Early response to neoadjuvant chemotherapy helps decrease recurrence rate of cervical cancer: a systematic review and meta-analysis.
    Hou Q; Shen J; Zhou S; Wei J; Wu M; Chen Q; Yan W; Zhang P; Yue Q; Wang S; Huang K
    Ann Palliat Med; 2021 Jun; 10(6):6092-6103. PubMed ID: 34118837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldehyde Dehydrogenase 1 Expression Predicts Chemoresistance and Poor Clinical Outcomes in Patients with Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemotherapy Prior to Radical Hysterectomy.
    Xie Q; Liang J; Rao Q; Xie X; Li R; Liu Y; Zhou H; Han J; Yao T; Lin Z
    Ann Surg Oncol; 2016 Jan; 23(1):163-70. PubMed ID: 25916979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized study.
    Chen H; Liang C; Zhang L; Huang S; Wu X
    Gynecol Oncol; 2008 Sep; 110(3):308-15. PubMed ID: 18606439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of neoadjuvant chemotherapy in different histological types of cervical cancer.
    He L; Wu L; Su G; Wei W; Liang L; Han L; Kebria M; Liu P; Chen C; Yu Y; Zhong M; Wang W
    Gynecol Oncol; 2014 Aug; 134(2):419-25. PubMed ID: 24918866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy increases the 5-year overall survival of patients with resectable cervical cancer: A systematic review and meta-analysis.
    Xu Y; Zhang M; Zhang J; Ng DM; Chen X; Si Y; Shi Y; Li X; Mao D; Yang L
    Taiwan J Obstet Gynecol; 2021 May; 60(3):433-441. PubMed ID: 33966724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential molecular mechanisms for improved prognosis and outcome with neoadjuvant chemotherapy prior to laparoscopical radical hysterectomy for patients with cervical cancer.
    Sun H; Xin J; Lu Z; Wang N; Liu N; Guo Q
    Cell Physiol Biochem; 2013; 32(5):1528-40. PubMed ID: 24335178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of tumor infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.
    Mao Y; Qu Q; Zhang Y; Liu J; Chen X; Shen K
    PLoS One; 2014; 9(12):e115103. PubMed ID: 25501357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44 isoform 6 (CD44v6) is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma.
    Costa S; Terzano P; Bovicelli A; Martoni A; Angelelli B; Santini D; Ceccarelli C; Lipponen P; Erzén M; Syrjänen S; Syrjänen K
    Gynecol Oncol; 2001 Jan; 80(1):67-73. PubMed ID: 11136572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis showing that early response to neoadjuvant chemotherapy predicts better survival among cervical cancer patients.
    Chen Z; Shi Y; Wang S; Lu Q
    Oncotarget; 2017 Aug; 8(35):59609-59617. PubMed ID: 28938664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant docetaxel combined with cisplatin and followed by radical surgery for the treatment of locally advanced (stage IB2 - IIB) cervical cancer: preliminary results of a single-institution experience.
    Huang X; Lan C; Huang H; Zhang Y; Huang H; Cao X; Huang Y; Guo Y; Wan T; Liu J
    Expert Opin Pharmacother; 2011 Feb; 12(2):165-73. PubMed ID: 21226631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy versus surgery for patients with cervical squamous cell carcinoma who have undergone neoadjuvant chemotherapy revisited.
    Furuta Y; Todo Y; Yamazaki H; Shimada C; Takeshita S; Okamoto K; Kato H
    Int J Clin Oncol; 2018 Feb; 23(1):126-133. PubMed ID: 28929314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy followed by radical hysterectomy plus postoperative chemotherapy but no radiotherapy for Stage IB2-IIB cervical cancer--irinotecan and platinum chemotherapy.
    Matsumura M; Takeshima N; Ota T; Omatsu K; Sakamoto K; Kawamata Y; Umayahara K; Tanaka H; Akiyama F; Takizawa K
    Gynecol Oncol; 2010 Nov; 119(2):212-6. PubMed ID: 20709382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncological outcome of complete response after neoadjuvant chemotherapy for breast conserving surgery: a systematic review and meta-analysis.
    Li X; Dai D; Chen B; Tang H; Wei W
    World J Surg Oncol; 2017 Nov; 15(1):210. PubMed ID: 29183336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.